U.S., Feb. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07402616) titled 'Ex Vivo Cutaneous SCC' on Jan. 14.
Brief Summary: This is a prospective study including patients ( >= 18 years) referred for surgical treatment of primary cutaneous squamous cell carcinoma at the Department of Plastic Surgery, Rigshospitalet. After written and informed consent, patients will undergo standard surgical excision, followed by ex vivo 3D ultrasonography of the specimen using a 3Sonic device connected to a high-frequency ultrasound machine. This will create 3D ultrasound tomographic scans which will be interpreted by one investigator blinded to histopathology. The investigated outcomes will primarily be the deep margin di...